Restylane Refyne, Restylane Defyne, and Restylane Kysse Injectable Gels
FDA premarket approval P140029/S028 · decided 2020-08-28
Approval details
- PMA number
- P140029
- Supplement
- S028
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane Refyne, Restylane Defyne, and Restylane Kysse Injectable Gels
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2020-07-29
- Decision date
- 2020-08-28
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Change the sterilization validation approach to the overkill method/full cycle approach defined in ISO 17665-1:2006 Annex D4.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.